Boryung Corporation (KRX:003850)

Market Cap	799.19B +11.1%
Revenue (ttm)	1.02T +0.0%
Net Income	64.30B -7.7%
EPS	765.85 -24.6%
Shares Out	84.48M
PE Ratio	12.35
Forward PE	21.12
Dividend	100.00 (1.06%)
Ex-Dividend Date	Dec 29, 2025

Volume	85,262
Average Volume	167,535
Open	9,360.00
Previous Close	9,460.00
Day's Range	9,340.00 - 9,690.00
52-Week Range	8,080.00 - 10,800.00
Beta	0.37
RSI	44.59
Earnings Date	May 22, 2026

About Boryung

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South K...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2025, Boryung's revenue was 1.02 trillion, an increase of 0.03% compared to the previous year's 1.02 trillion. Earnings were 64.30 billion, a decrease of -7.65%.